HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alberto-Culver

This article was originally published in The Rose Sheet

Executive Summary

Company completes buyback of $200 mil. of 8.25% senior notes due Nov. 1, 2005, Alberto-Culver announces Sept. 15. Redemption will result in $12.6 mil. pre-tax charge in the fourth quarter and will lower net interest expense by approximately $14.3 mil. over remaining original term of the notes, Alberto says. Company likely will use interest expense savings to boost advertising, marketing and other investment to support global brands and businesses, firm notes. Alberto President and CEO Howard Bernick announced plans to increase firm's advertising efforts earlier this month (1"The Rose Sheet" Sept. 13, 2004, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel